Steward Partners Investment Advisory’s Definium Therapeutics DFTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Sell	11,540 -1,700	-13%	-$42K	﹤0.01%	1651
2026 Q1	$250K	Buy	13,240 +12,240	+1,224%	+$208K	﹤0.01%	1904
2025 Q4	$13.4K	Hold	1,000	–	–	﹤0.01%	3316
2025 Q3	$11.8K	Hold	1,000	–	–	﹤0.01%	3329
2025 Q2	$6.49K	Hold	1,000	–	–	﹤0.01%	3388
2025 Q1	$5.85K	Buy	1,000 +100	+11%	+$716	﹤0.01%	3331
2024 Q4	$6.26K	Buy	900 +400	+80%	+$2.75K	﹤0.01%	3287
2024 Q3	$2.85K	Buy	+500	New	+$3.48K	﹤0.01%	3364
2024 Q2	–	Sell	-6	Closed	-$56	–	3674
2024 Q1	$56	Hold	6	–	–	﹤0.01%	3520
2023 Q4	$22	Buy	+6	New	+$18	﹤0.01%	3476
2022 Q1	–	Sell	-180	Closed	-$4K	–	3336
2021 Q4	$4K	Hold	180	–	–	﹤0.01%	2893
2021 Q3	$6K	Hold	180	–	–	﹤0.01%	2757
2021 Q2	$9K	Buy	+180	New	+$9.45K	﹤0.01%	6257

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Steward Partners Investment Advisory's DFTX Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Definium Therapeutics (DFTX) stake by 13% in Q2 2026, selling an estimated $42K and leaving 11,540 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Steward Partners Investment Advisory first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Steward Partners Investment Advisory held 11,540 shares of Definium Therapeutics worth $543K as of Q2 2026.
Steward Partners Investment Advisory sold 1,700 Definium Therapeutics shares in Q2 2026, an estimated $42K.
Definium Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1651 holding.
Steward Partners Investment Advisory first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.